Correspondence on Editorial regarding “Identification of signature gene set as highly accurate determination of MASLD progression”

키워드

참고문헌 (8)

1. Pirola CJ, "The gene expression signature of MASLD from a multiomics perspective", Clin Mol Hepatol, 30, pp.174~176 (2024)
2. Oh S, "Identification of signature gene set as highly accurate determination of MASLD progression", Clin Mol Hepatol, 30, pp.247~262 (2024)
3. Dhamija E, "Non-alcoholic fatty liver disease associated with hepatocellular carcinoma : An increasing concern", Indian J Med Res, 149, pp.9~17 (2019)
4. Hernandez Roman J, "The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease", Endocrinol Diabetes Metab, 3, pp.e00127~ (2020)
5. Oh S, "From genome sequencing to the discovery of potential biomarkers in liver disease", BMB Rep, 53, pp.299~310 (2020)
6. Ramachandran P, "Resolving the fibrotic niche of human liver cirrhosis at single-cell level", Nature, 575, pp.512~518 (2019)
7. Han Z, "RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma", Sci Rep, 11, pp.17797~ (2021)
8. Chalasani N, "Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization", Am J Physiol Gastrointest Liver Physiol, 320, pp.G439~G449 (2021)

관련 논문AI추천